Johnson Chemical Pharmaceutical Works Co., Ltd. More Details
Excellent balance sheet average dividend payer.
Share Price & News
How has Johnson Chemical Pharmaceutical Works's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4747 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 1% a week.
Volatility Over Time: 4747's weekly volatility (1%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 4747 underperformed the TW Pharmaceuticals industry which returned 31.8% over the past year.
Return vs Market: 4747 underperformed the TW Market which returned 31.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Johnson Chemical Pharmaceutical Works's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StEstimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)
1 month ago | Simply Wall StIs Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?
1 month ago | Simply Wall StJohnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?
Is Johnson Chemical Pharmaceutical Works undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 4747 (NT$36.35) is trading above our estimate of fair value (NT$34.99)
Significantly Below Fair Value: 4747 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 4747 is good value based on its PE Ratio (15.2x) compared to the TW Pharmaceuticals industry average (17.9x).
PE vs Market: 4747 is good value based on its PE Ratio (15.2x) compared to the TW market (18.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 4747's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 4747 is good value based on its PB Ratio (1.3x) compared to the TW Pharmaceuticals industry average (2.1x).
How is Johnson Chemical Pharmaceutical Works forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Johnson Chemical Pharmaceutical Works has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Johnson Chemical Pharmaceutical Works is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Johnson Chemical Pharmaceutical Works performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4747 has a high level of non-cash earnings.
Growing Profit Margin: 4747's current net profit margins (16.1%) are higher than last year (14.8%).
Past Earnings Growth Analysis
Earnings Trend: 4747's earnings have grown by 1.1% per year over the past 5 years.
Accelerating Growth: 4747's earnings growth over the past year (17.8%) exceeds its 5-year average (1.1% per year).
Earnings vs Industry: 4747 earnings growth over the past year (17.8%) underperformed the Pharmaceuticals industry 23.3%.
Return on Equity
High ROE: 4747's Return on Equity (8.5%) is considered low.
How is Johnson Chemical Pharmaceutical Works's financial position?
Financial Position Analysis
Short Term Liabilities: 4747's short term assets (NT$536.0M) exceed its short term liabilities (NT$244.9M).
Long Term Liabilities: 4747's short term assets (NT$536.0M) exceed its long term liabilities (NT$1.3M).
Debt to Equity History and Analysis
Debt Level: 4747's debt to equity ratio (17.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 4747's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 4747's debt is well covered by operating cash flow (58.2%).
Interest Coverage: 4747 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Johnson Chemical Pharmaceutical Works's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4747's dividend (4.95%) is higher than the bottom 25% of dividend payers in the TW market (2.09%).
High Dividend: 4747's dividend (4.95%) is low compared to the top 25% of dividend payers in the TW market (5.15%).
Stability and Growth of Payments
Stable Dividend: 4747's dividends per share have been stable in the past 10 years.
Growing Dividend: 4747's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (75.2%), 4747's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. P.H Huang serves as Chairman & Chief Executive Officer at Johnson Chemical Pharmaceutical Works Co., Ltd. Mr. Huang began his career with JCP in 1972 as a sales assistant, and subsequently served in a ...
|Chairman & CEO||22yrs||no data||no data|
|Finance Director||7yrs||no data||no data|
|Sales Director||11yrs||no data||no data|
|Deputy General Manager and Director||no data||no data||no data|
|Chief Research Officer||no data||no data||no data|
Experienced Management: 4747's management team is seasoned and experienced (11 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Johnson Chemical Pharmaceutical Works Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Johnson Chemical Pharmaceutical Works Co., Ltd.
- Ticker: 4747
- Exchange: GTSM
- Founded: 1966
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: NT$1.099b
- Shares outstanding: 30.02m
- Website: https://www.jcpjohnson.com.tw
Number of Employees
- Johnson Chemical Pharmaceutical Works Co., Ltd.
- 31, San Ho Road
- Sec. 4
- New Taipei City
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|4747||GTSM (Taipei Exchange)||Yes||Common Stock||TW||TWD||Jan 2010|
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures and sells pharmaceutical materials and products in Taiwan. The company offers its products in various therapeutic areas, including central nervo...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/26 17:17|
|End of Day Share Price||2021/01/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.